Mendelian Randomization Analysis in Observational Epidemiology

다국어 초록 (Multilingual Abstract)

Mendelian randomization (MR) in epidemiology is the use of genetic variants as instrumental variables (IVs) in non-experimental design to make causality of a modifiable exposure on an outcome or disease. It assesses the causal effect between risk factor and a clinical outcome. The main reason to approach MR is to avoid the problem of residual confounding. There is no association between the genotype of early pregnancy and the disease, and the genotype of an individual cannot be changed. For this reason, it results with randomly assigned case-control studies can be set by regressing the measurements. IVs in MR are used genetic variants for estimating the causality. Usually an outcome is a disease and an exposure is risk factor, intermediate phenotype which may be a biomarker. The choice of the genetic variable as IV (Z) is essential to a successful in MR analysis. MR is named ‘Mendelian deconfounding’ as it gives to estimate of the causality free from biases due to confounding (C). To estimate unbiased estimation of the causality of the exposure (X) on the clinically relevant outcome (Y), Z has the 3 core assumptions (A1-A3). A1) Z is independent of C; A2) Z is associated with X; and A3) Z is independent of Y given X and C; The purpose of this review provides an overview of the MR analysis and is to explain that using an IV is proposed as an alternative statistical method to estimate causal effect of exposure and outcome under controlling for a confounder.

참고문헌 (Reference)

1 Wehby GL, "‘Mendelian randomization’ equals instrumental variable analysis with genetic instruments" 27 : 2745-2749, 2008

2 Wright S, "The tariff on animal and vegetable oils" Macmillan 1928

3 Ding W, "The impact of poor health on academic performance: New evidence using genetic markers" 28 : 578-597, 2009

4 Goldberger AS, "Structural equation methods in the social sciences" 40 : 979-1001, 1972

5 Bech BH, "Stillbirth and slow metabolizers of caffeine:comparison by genotypes" 35 : 948-953, 2006

6 인준용, "Randomization in clinical studies" 대한마취통증의학회 72 (72): 221-232, 2019

7 Yavorska O, "Package ‘MendelianRandomization’"

8 Yavorska OO, "MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data" 46 : 1734-1739, 2017

9 Lawlor DA, "Mendelian randomization: using genes as instruments for making causal inferences in epidemiology" 27 : 1133-1163, 2008

10 Burgess S, "Mendelian randomization: methods for using genetic variants in causal estimation" CRC Press 2015

11 Ebrahim S, "Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?" 123 : 15-33, 2008

12 Jansen H, "Mendelian randomization studies in coronary artery disease" 35 : 1917-1924, 2014

13 Smith GD, "Mendelian randomization for strengthening causal inference in observational studies:application to gene × environment interactions" 5 : 527-545, 2010

14 Didelez V, "Mendelian randomization as an instrumental variable approach to causal inference" 16 : 309-330, 2007

15 Sekula P, "Mendelian randomization as an approach to assess causality using observational data" 27 : 3253-3265, 2016

16 Mumby HS, "Mendelian randomisation study of childhood BMI and early menarche" 2011 : 180729-, 2011

17 Nitsch D, "Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials" 163 : 397-403, 2006

18 Gray R, "How to avoid bias when comparing bone marrow transplantation with chemotherapy" 7 (7): 9-12, 1991

19 Casas JP, "Homocysteine and stroke: evidence on a causal link from mendelian randomisation" 365 : 224-232, 2005

20 부소영, "Genetically Mediated Lipid Metabolism and Risk of Insulin Resistance: Insights from Mendelian Randomization Studies" 한국지질동맥경화학회 8 (8): 132-143, 2019

21 von Hinke Kessler Scholder S, "Genetic markers as instrumental variables: an application to child fat mass and academic achievement" The Centre for Market and Public Organisation 2010

22 Ference BA, "Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis" 60 : 2631-2639, 2012

23 Lim HR, "Effect of blood lead concentration on attention deficit hyperactivity disorder in Korean children:a Mendelian randomization study" Seoul National University 2017

24 Kivimäki M, "Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study" 3 : e52-, 2008

25 Greco M FD, "Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome" 34 : 2926-2940, 2015

26 Teumer A, "Common methods for performing mendelian randomization" 5 : 51-, 2018

27 Thomas DC, "Commentary: the concept of ‘Mendelian randomization’" 33 : 21-25, 2004

28 Tobin MD, "Commentary: development of Mendelian randomization:from hypothesis test to ‘Mendelian deconfounding’" 33 : 26-29, 2004

29 Wheatley K, "Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia" 33 : 15-17, 2004

30 Pearl J, "Causality" Cambridge University Press 2000

31 Ogbuanu IU, "Can we apply the Mendelian randomization methodology without considering epigenetic effects?" 6 : 3-, 2009

32 Timpson NJ, "C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization" 35 : 300-308, 2011

33 Allin KH, "C-reactive protein and the risk of cancer: a mendelian randomization study" 102 : 202-206, 2010

34 Timpson NJ, "C-reactive protein and its role in metabolic syndrome: mendelian randomisation study" 366 : 1954-1959, 2005

35 Almon R, "Associations between lactase persistence and the metabolic syndrome in a cross-sectional study in the Canary Islands" 49 : 141-146, 2010

36 Trompet S, "Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study" 170 : 1415-1421, 2009

37 Greenland S, "An introduction to instrumental variables for epidemiologists" 29 : 722-729, 2000

38 Chen L, "Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach" 5 : e52-, 2008

39 Burgess S, "A review of instrumental variable estimators for Mendelian randomization" 26 : 2333-2355, 2017